suberoyl bis-hydroxamic acid has been researched along with Acute Lymphoid Leukemia in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, N | 1 |
| Zou, J | 1 |
| Li, J | 1 |
| Chen, F | 1 |
| Dai, J | 1 |
| Qu, X | 1 |
| Sun, X | 1 |
| Ma, D | 1 |
| Ji, C | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
Topics: Apoptosis; beta Catenin; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell | 2012 |